Development of an outer membrane vesicles (OMVs) based antigen presentation platform for AR-23 antiviral peptide. AR-23 peptide was exposed on the surface of vesicles produced by bacteria recombinantly expressing a chimeric protein allowing AR-23 membrane anchoring.AR23-functionalized OMV were screened for antiviral activity against HSV-1 in comparison to CTRL OMVs